[go: up one dir, main page]

PE20100130A1 - Extracto de cafe - Google Patents

Extracto de cafe

Info

Publication number
PE20100130A1
PE20100130A1 PE2009000582A PE2009000582A PE20100130A1 PE 20100130 A1 PE20100130 A1 PE 20100130A1 PE 2009000582 A PE2009000582 A PE 2009000582A PE 2009000582 A PE2009000582 A PE 2009000582A PE 20100130 A1 PE20100130 A1 PE 20100130A1
Authority
PE
Peru
Prior art keywords
coffee extract
produce
coffee
extract
acids
Prior art date
Application number
PE2009000582A
Other languages
English (en)
Inventor
Rachid Bel-Rhlid
Karin Kraehenbuehl
Christophe Cavin
Thomas Wolfgang Raab
Nicolas Page
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PE20100130A1 publication Critical patent/PE20100130A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
    • A23F5/26—Extraction of water soluble constituents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/02—Treating green coffee; Preparations produced thereby
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
    • A23F5/246—Addition of, or treatment with, enzymes or microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)

Abstract

REFERIDO A UN METODO PARA PRODUCIR UN EXTRACTO DE CAFE CON PROPIEDADES ANTIOXIDANTES Y ANTI-INFLAMATORIAS, QUE COMPRENDE LAS SIGUIENTES ETAPAS: A) EXTRAER GRANOS DE CAFE CON AGUA PARA PRODUCIR UN EXTRACTO DE CAFE; Y B) TRATAR EL EXTRACTO DE CAFE HIDROLIZANDO ACIDOS CLOROGENICOS MEDIANTE FERMENTACION CON UN MICROORGANISMO PARA GENERAR ACIDOS FENOLICOS
PE2009000582A 2008-04-30 2009-04-29 Extracto de cafe PE20100130A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08155448 2008-04-30

Publications (1)

Publication Number Publication Date
PE20100130A1 true PE20100130A1 (es) 2010-03-02

Family

ID=39789542

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2009000582A PE20100130A1 (es) 2008-04-30 2009-04-29 Extracto de cafe

Country Status (18)

Country Link
US (1) US20110045106A1 (es)
EP (1) EP2282643A1 (es)
JP (1) JP2011520429A (es)
KR (1) KR20110004400A (es)
CN (1) CN102014650A (es)
AR (1) AR071426A1 (es)
AU (1) AU2009242333A1 (es)
BR (1) BRPI0911496A2 (es)
CA (1) CA2723050A1 (es)
CL (1) CL2009001031A1 (es)
CO (1) CO6280593A2 (es)
MX (1) MX2010011058A (es)
PE (1) PE20100130A1 (es)
RU (1) RU2010148738A (es)
TW (1) TW200944131A (es)
UY (1) UY31799A (es)
WO (1) WO2009132888A1 (es)
ZA (1) ZA201008550B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103313613B (zh) * 2010-10-13 2016-04-06 洲际大品牌有限责任公司 作为食物、药物、化妆品、膳食补充剂和生物制品的成分的咖啡提取物
KR101074839B1 (ko) * 2010-11-25 2011-10-19 주식회사 녹십자 금은화 추출물을 포함하는 역류성 식도염 치료 또는 예방용 약학조성물
JP5831920B2 (ja) * 2011-03-29 2015-12-09 雪印メグミルク株式会社 フェルラ酸含有画分の製造方法
CN103360258A (zh) * 2013-08-08 2013-10-23 内蒙古鑫吉利生物科技有限公司 一种从咖啡豆中提取绿原酸的方法
JP6129762B2 (ja) * 2013-10-04 2017-05-17 富士フイルム株式会社 クロロゲン酸含有組成物の製造方法
CN103705600B (zh) * 2013-12-26 2015-06-17 晨光生物科技集团股份有限公司 一种绿咖啡豆提取物的生产方法
KR20180054660A (ko) * 2015-09-04 2018-05-24 코페 푸르트 피티이. 엘티디. 커피 열매 추출물 및 분말의 제조
PT108986B (pt) * 2015-11-27 2022-10-31 Novadelta Comercio E Ind De Cafes Lda Revestimento edível, sistema de produtos edíveis apresentando o referido revestimento edível e uso do referido sistema
CN105494825B (zh) * 2015-12-05 2019-02-12 田铠铭 抗氧化养身咖啡
CN106176451A (zh) * 2016-08-26 2016-12-07 施协均 一种基于咖啡葡萄果植物提取物的护肤品及其制备方法
HUE057163T2 (hu) * 2017-10-04 2022-04-28 Nestle Sa Eljárás pörkölt kávébab elõállítására
KR101980816B1 (ko) * 2017-11-15 2019-05-22 대한민국 이탈리안라이그라스로부터 추출된 페룰산을 유효성분으로 함유하는 비만의 예방, 치료 또는 개선용 조성물
KR102088187B1 (ko) * 2018-11-23 2020-03-12 대구가톨릭대학교산학협력단 커피 생두 추출물의 분말 제조방법
KR102157795B1 (ko) 2018-12-06 2020-09-18 (주)녹십자웰빙 금은화 물 추출물을 포함하는 헬리코박터 파일로리 감염증 예방 또는 치료용 약학 조성물
WO2020193752A1 (en) * 2019-03-27 2020-10-01 Société des Produits Nestlé S.A. Use of green coffee based compositions for improving insulin profile
CN113613720A (zh) * 2019-04-10 2021-11-05 雀巢产品有限公司 用于通过增强流动介导的扩张来改善内皮功能的组合物
EP4167747A1 (en) * 2020-06-17 2023-04-26 Société des Produits Nestlé S.A. Stabilization of lc-pufas by side stream product from green coffee decaffeination
KR102596021B1 (ko) * 2021-01-25 2023-11-01 대전대학교 산학협력단 커피, 커피추출물 및 부산물을 유효성분으로 포함하는 암의 전이 예방, 개선 또는 치료용 조성물
AU2022371647B2 (en) * 2021-10-24 2025-04-03 P.L. Thomas & Co., Inc. Borate complexes of chlorogenic acid and uses thereof
JP2024136754A (ja) * 2023-03-24 2024-10-04 ピアス株式会社 樹状細胞の遊走抑制剤、皮膚外用組成物、化粧料、及び医薬品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005757A (en) * 1960-11-14 1961-10-24 James C Lewis Preparation of chlorogenicase
US3788860A (en) * 1972-06-23 1974-01-29 Gen Foods Corp Process for producing coffee extract
US20020160067A1 (en) * 2001-04-25 2002-10-31 Oncology Science Corporation Therapeutic preparation and method for producing a therapeutic preparation using coffee beans as a substrate
JP3548102B2 (ja) * 2000-08-07 2004-07-28 花王株式会社 高血圧症予防・治療剤
ITMI20031396A1 (it) * 2003-07-09 2005-01-10 Giuliani Spa Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
JP4499665B2 (ja) * 2003-10-06 2010-07-07 オリザ油化株式会社 ダイエット用組成物
JP4873444B2 (ja) * 2005-06-03 2012-02-08 日本たばこ産業株式会社 血液凝固遅延剤

Also Published As

Publication number Publication date
EP2282643A1 (en) 2011-02-16
KR20110004400A (ko) 2011-01-13
BRPI0911496A2 (pt) 2015-07-28
AR071426A1 (es) 2010-06-16
CN102014650A (zh) 2011-04-13
UY31799A (es) 2009-11-10
AU2009242333A1 (en) 2009-11-05
TW200944131A (en) 2009-11-01
CO6280593A2 (es) 2011-05-20
MX2010011058A (es) 2010-11-01
CL2009001031A1 (es) 2010-08-20
JP2011520429A (ja) 2011-07-21
WO2009132888A1 (en) 2009-11-05
US20110045106A1 (en) 2011-02-24
ZA201008550B (en) 2012-05-30
RU2010148738A (ru) 2012-06-10
CA2723050A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
PE20100130A1 (es) Extracto de cafe
PE20100129A1 (es) Productos que comprenden acidos fenolicos descarboxilados derivados de acidos clorogenicos de cafe, y sus usos
AR085943A1 (es) Composicion antimicrobiana
MY158663A (en) Fermentation broth formulations
EP4613223A3 (en) Systems and methods for prostate treatment
ITTO20100446A1 (it) Uso di un estratto vegetale ricco di polifenoli come agente antiossidante in associazione con un agente idratate oppure umettante.
PE20181132A1 (es) Bacteria de lactobacillus fermentum que inhibe la posacidificacion
BR112014013172A2 (pt) extratos de maesa japonica e métodos de uso
DK2227552T3 (da) Forøgede folatproduktionsniveauer ved fermentering af melonsalf med Lactobacillus
WO2010039499A3 (en) Targeted advertising using object identification
UY31798A (es) Composiciones para preparar una bebida
ES2570990T3 (es) Alimento fermentado que contiene bacterias bifidobacterium y método para producir el mismo
Conde et al. Extraction of natural antioxidants from plant foods
BR112016006383A8 (pt) métodos para extração de uma proteína solúvel, produção de uma composição e produção de um suporte sólido ou semissólido
MX374590B (es) Composición para usarse en el tratamiento de la tos.
MX2012007587A (es) Composiciones nutricionales que comprenden hojuelas de frutas que incluyen acido docosahexaenoico.
CL2012002335A1 (es) Metodo para producir arginina mediante la fermentacion de agro-residuos en la presencia de por lo menos una corynebacterium glutamicum atcc 21831 o corynebacterium glutamicum atcc 21493 para producir un licor fermentado que contiene arginina y recuperarla del licor.
AR076693A1 (es) Procedimientopara preparar un producto fermentado a base de soja
CL2012002504A1 (es) Extracto de cafe que comprende al menos 1 miligramo de un ion multivalente por gramo de solidos de cafe; y metodo de produccion.
WO2011140226A3 (en) Compositions comprising extracts of southernwood and an amine compound
UY34267A (es) Métodos para aumentar el contenido de proteínas,aceites y/o aminoácidos en una planta
CL2015003744A1 (es) Metodología para la elaboración de bebidas fermentadas reducidas en etanol
RU2011112587A (ru) Способ получения растительных экстрактов
WO2011020879A3 (en) Use of an extract obtained from plants of the sub-family rutoideae in the treatment of cancer
AR087586A1 (es) Sistema enzimatico

Legal Events

Date Code Title Description
FD Application declared void or lapsed